Effectiveness of post-transplant prophylaxis with anti-hepatitis B virus (HBV) immunoglobulin in heart transplant patients with anti-HBV core antibodies and in recipients of organs from HBV core antibody positive donors

被引：0
|
作者：
Cantarovich, M. [1 ]
Gianetti, N. [1 ]
Tchevenkov, J. [1 ]
Cyr, E. [1 ]
Cencic, D. [1 ]
Fontaine, G. [1 ]
Cecere, R. [1 ]
机构：
[1] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2006年 / 25卷 / 02期
关键词：
D O I：
10.1016/j.healun.2005.11.287
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
276
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [31] HBV DNA PCR positive rates of antibody to hepatitis B core (anti-HBc) repeat reactive (RR) donors; Implications for reentry protocols
    Stramer, S. L.
    Foster, G. A.
    Notari, E. P.
    TRANSFUSION, 2006, 46 (09) : 21A - 21A
  • [32] A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis
    Han, Seunghoon
    Na, Gun Hyung
    Kim, Dong-Goo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2099 - 2107
  • [33] POST-TRANSPLANT OUTCOMES FOR HEPATITIS B CORE ANTIBODY OR SURFACE ANTIGEN POSITIVE DONORS - OPPORTUNITY TO EXPAND DONOR POOL
    Bhatnagar, Anshul
    Prakash, Sameer
    Cholankeril, Rossann
    Lymberopoulos, Peter
    Ahmed, Aijaz
    Goff, Cameron
    Kim, Donghee
    Kim, Hyun-Seok
    Flores, Avegail G.
    Goss, John A.
    Rana, Abbas
    Kanwal, Fasiha
    Cholankeril, George
    Lee, Tzu-Hao
    HEPATOLOGY, 2022, 76 : S520 - S521
  • [34] Vaccination with an experimental anti-HBV vaccine yields high response rates in liver transplant patients and allows safe discontinuation of hepatitis B immunoglobulins prophylaxis.
    Starkel, P
    Bouvier, A
    Stoffel, M
    Lerut, J
    Horsmans, Y
    HEPATOLOGY, 2004, 40 (04) : 189A - 189A
  • [35] Hepatitis B core-related antigen and anti-hepatitis B core antibody are not associated with liver fibrosis evolution in HIV-HBV co-infected patients during treatment with tenofovir
    Cruchet, R.
    Dezanet, L.
    Gabassi, A.
    Maylin, S.
    Rougier, H.
    Miailhes, P.
    Lascoux-Combe, C.
    Chas, J.
    Girard, P-M
    Delaugerre, C.
    Lacombe, K.
    Boyd, A.
    HIV MEDICINE, 2019, 20 : 302 - 303
  • [36] Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients
    Bizollon, T
    Ahmed, SNS
    Guichard, S
    Chevallier, P
    Adham, M
    Ducerf, C
    Baulieux, J
    Trepo, C
    GUT, 2000, 47 (05) : 698 - 702
  • [37] EFFECTIVE PROPHYLAXIS FOR HEPATITIS B VIRUS (HBV) REINFECTION AFTER LIVER TRANSPLANTATION (TX) FOLLOWING SWITCH TO SUBCUTANEOUS (SC) HEPATITIS B IMMUNOGLOBULIN (HBIG) BY WEEK 2 POST-TRANSPLANT (TX)
    De Simone, Paulo
    Salizoni, Mauro
    Pinna, Antonio D.
    Cillo, Umberto
    Zamboni, Fausto
    Mutimer, David
    Samuel, Didier
    TRANSPLANT INTERNATIONAL, 2015, 28 : 20 - 20
  • [38] Performance Evaluation of Four Dominant Anti-Hepatitis B Core Antigen (HBcAb) Kits in Japan for Preventing de novo Hepatitis B Virus (HBV) Infection
    Kobayashi, Eiji
    Deguchi, Matsuo
    Kagita, Masanori
    Yoshioka, Nori
    Kita, Mifumi
    Asari, Seishi
    Suehisa, Etsuji
    Hidaka, Yoh
    Iwatani, Yoshinori
    CLINICAL LABORATORY, 2015, 61 (1-2) : 77 - 85
  • [39] Are liver grafts from hepatitis B surface antigen negative/anti-hepatitis B core antibody positive donors suitable for transplantation?
    Nery, JR
    Gedaly, R
    Vianna, R
    Berho, M
    Weppler, D
    Levi, D
    Kato, T
    Khan, F
    Pinna, A
    Schiff, E
    Tzakis, A
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1521 - 1522
  • [40] CHARACTERIZATION OF IGM ANTIBODY TO HEPATITIS-B CORE ANTIGEN (IGM ANTI-HBC) IN CHRONIC HEPATITIS-B VIRUS (HBV) INFECTIONS
    SJOGREN, MH
    LEMON, SM
    BANCROFT, WH
    HEPATOLOGY, 1984, 4 (05) : 1095 - 1095
12345